… At month 7, vaccineinduced type-specific antibody titer was high. In conclusion, … VLP vaccine
to Korean women aged 9–23 years was generally well tolerated and highly immunogenic. …

… vaccine for … immunogenicity of our OCV in adult Korean male. Upon achieving the successful
outcome from this study, phase III clinical trial of this OCV with a large number of subjects …

… immunogenicity populations included eligible subjects who … all-available immunogenicity
population included all subjects … those of the evaluable immunogenicity population, data are …

… vaccine was more immunogenic against the four serogroup B test strains than the control
vaccines (… of Korean subjects to 4CMenB vaccination, the study population contains only …

… clinical trial with Korean patients with CHB, HB-110 vaccine was not … seroconversion rate
was lower in Korean patients (one of six … subjects who received the HB-110 than in Caucasian …

… vaccine. The objective of this study was to confirm the immunogenicity and safety of Intanza/IDflu
in South Korean adults. … Subjects were vaccinated with 9 μg ID vaccine or with 15 μg IM …

… Subjects Intended subjects were Korean infants who were eligible for inclusion if they were
2 months-old (56-70 days) on the day of enrolment, had been born full-term (≥ 37 weeks) …

… Therefore, we compared 2 vaccines in unprimed subjects. … vaccine induced more
immunogenicity than the SU vaccine in … SPL influenza vaccine may be preferable to the SU …

… Immunogenicity as measured by seroresponse was predefined in this study as contingent
upon pre-vaccination hSBA titers: for baseline seronegative subjects (hSBA titers <4), …

… Subjects were excluded if they had previous vaccination with any VZV-… immunogenicity of
the zoster vaccine is good in Korean adults, the efficacy and the effectiveness of the vaccine for …